Bruker to supply mycobacterium genotype testing for Belfast TB lab
- BSO Procurement and Logistics Service (PaLS)
- Northern Ireland
- Open procedure, 1 bid
- 12 January 2027 to 11 January 2033
BSO Procurement and Logistics Service (PaLS) has chosen Bruker to supply genotype testing for mycobacterium. The work will serve the tuberculosis laboratory in Belfast Health and Social Care Trust's microbiology department.
The laboratory wants an automated molecular method for naming the mycobacterium species grown from positive cultures. Bruker's solution will take each sample from arrival to final identification, analysing results automatically and storing them digitally. The contract also covers reagents and consumables, upkeep of the equipment and training for staff.
The open tender drew one bid, with quality making up 30% of the assessment. Bruker was awarded £263,359 in June 2026, below the estimate of £366,588. The six-year contract will start in January 2027, with an option to extend by up to 24 months.
Contract ends January 2033
- What
- PCR and molecular diagnostic platforms
- Supplier
- Bruker
- Value
- £263,359
- How it was bought
- Open procedure
- 1 bid
- Dates and next
- Jan 2027 to Jan 2033
- Option to Jan 2035